▮ DFV TERMINAL
--:--:-- UTC SIGN IN
F1 Terminal / GSCE

GSCE — GOLDMAN SACHS GROUP INC

—
NYSE · Financials · Capital Markets · CIK 886982 ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—
Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. The company operates Automation Enabling Technologies and Medical Solutions segments. The Precision Medicine and Manufacturing segment designs, manufactures, and markets laser beam steering and scanning solutions, laser sources, robotic and precision motion, robotic end-of-arm tooling, and bearing spindles. This segment serves advanced industrial processes, advanced industrial and medical robotics, other medical and life science automation applications, and medical laser procedures, such as ophthalmology applications. The Medical Solutions segment provides a range of medical grade technologies, including medical insufflators, pumps, and related disposables; imaging, identification and RFID solutions; advanced motion control solutions; and light engines, and integrated operating room technologies. The company was formerly known as GSI Group, Inc. and changed its name to Novanta Inc. in May 2016. Novanta Inc. was incorporated in 1968 and is based in Bedford, Massachusetts.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Dec 2024 15,436,000,000 21,448,000,000 15,406,000,000 2,990,000,000 1,675,972,000,000 182,092,000,000 1,553,976,000,000
Dec 2023 14,255,000,000 18,257,000,000 11,309,000,000 2,058,000,000 1,641,594,000,000 241,577,000,000 1,524,689,000,000
Dec 2022 14,511,000,000 8,550,000,000 -3,607,000,000 3,069,000,000 1,441,799,000,000 241,825,000,000 1,324,610,000,000
Dec 2021 18,016,000,000 3,117,000,000 -3,346,000,000 5,378,000,000 1,463,988,000,000 261,036,000,000 1,354,062,000,000

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2024 56,261,000,000 40,851,000,000 8,516,000,000 1,675,972,000,000 1,553,976,000,000 — —
Dec 2023 58,759,000,000 1,805,000,000 11,261,000,000 1,641,594,000,000 1,524,689,000,000 — —
Dec 2022 77,065,000,000 -20,367,000,000 21,635,000,000 1,441,799,000,000 1,324,610,000,000 — —
Dec 2021 57,199,000,000 -16,393,000,000 9,459,000,000 1,463,988,000,000 1,354,062,000,000 — —

TTM Snapshot

Revenues TTM
$59,382,000,000
NetIncome TTM
$10,096,000,000
OpCashFlow TTM
$0
Assets (Latest)
$1,675,972,000,000
Forward EPS
—

Peers — same industry

TickerNameMarket CapLastDaily %
MS MORGAN STANLEY $354.83B $224.96 —
GS GOLDMAN SACHS GROUP INC $324.25B $1099.14 —
SCHW SCHWAB CHARLES CORP $164.37B $94.51 —
BLK BlackRock, Inc. $164.14B $1057.38 —
GLD SPDR GOLD TRUST $101.15B $388.60 —

Recent Insider Activity

No insider activity indexed for this ticker.
SEC EDGAR filings → · StockAnalysis.com → · OpenInsider →